In Vitro and In Vivo Evaluation of Curcuma Comosa Liquisolid Tablets

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-C-047-Monday
• By: LIMPONGSA, Ekapol (Faculty of Pharmaceutical Sciences, Khon Kaen University, Pharmaceutical Technology, khon kaen, Thailand)
• Co-author(s): Ekapol Limpongsa: Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Khon Kaen University, khon kaen, Thailand
  Napaphak Jaipakdee: Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Khon Kaen University, khon kaen, Thailand
  Bungorn Sripanidkulchai: for Research and Development of Herbal Health Products, Faculty of Pharmaceutical Sciences, Khon Kaen University, khon kaen, Thailand
  Pawinee Piyachaturawat: Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand
  
• Abstract:

  Backgrounds

  The rhizome of Curcuma comosa Roxb. (CC) is widely used for health promotion in postmenopausal women in Thailand. The estrogenic-like activities of CC extract are related to its major constituents, diarylheptanoids, of which the (4E, 6E)-1, 7-diphenylhepta-4, 6-dien-3-ol (DA1) and (6E)-1, 7-diphenylhept-6-en-3-ol (DA2) were identified..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login